India outlines 14 "essential elements" of informed consent for drug trials
This article was originally published in Scrip
Companies that are sponsors of clinical trials undertaken in India will have to abide be new requirements for informed consent documents. India's Central Drugs Standard Control Organization has laid out 14 "essential elements" that must be included in such documents used to enrol subjects in a drug trial.
You may also be interested in...
Five new drugs have been recommended for EU approval at the latest meeting of European Medicines Agency’s drug evaluation committee.
The European Commission has set aside, for now, concerns expressed by member states regarding the scope of medicines subjected to additional monitoring requirements.
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.